SCHEMBL1733894

SCHEMBL1733894

N=C(NN)c1ccc2nc(C(=O)O)cn2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.48
PTGS2 P35354 1/20 0.48
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALDH1A1 P00352 4/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
KDM4E B2RXH2 3/20 0.43
POLB P06746 2/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
EGLN1 Q9GZT9 8/20 0.43
MEN1 O00255 1/20 0.38
HSP90AA1 P07900 1/20 0.38
KMT2A Q03164 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CCNB2 O95067 1/20 0.37
CCNE2 O96020 1/20 0.37
CDK1 P06493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764188 0.82 KDM4E (0.55) MAPTCYP1A2CYP3A4ALDH1A1NPC1
SCHEMBL9753842 0.81 PTGS1 (0.59) PTGS1PTGS2MAPTCYP1A2CYP3A4
SCHEMBL327269 0.80 PTGS1 (0.54) PTGS1PTGS2MAPTCYP1A2CYP3A4
SCHEMBL22147857 0.77 PTGS1 (0.54) PTGS1PTGS2MAPTALDH1A1NPC1
SCHEMBL21033164 0.77 PTGS1 (0.50) PTGS1PTGS2MAPTCYP1A2CYP3A4
SCHEMBL22531167 0.75 PTGS1 (0.49) PTGS1PTGS2MAPTCYP1A2CYP3A4
SCHEMBL22531166 0.75 PTGS1 (0.49) PTGS1PTGS2MAPTCYP1A2CYP3A4
SCHEMBL1733275 0.74 KDM4E (0.49) PTGS1PTGS2MAPTCYP1A2ALDH1A1
SCHEMBL23534418 0.74 PTGS1 (0.50) PTGS1PTGS2MAPTCYP3A4ALDH1A1
SCHEMBL2485534 0.73 PTGS1 (0.57) PTGS1PTGS2MAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225240-B1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof SANOFI SA (FR) 2014-01-22 EP claimed
EP-2225240-B1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof SANOFI SA (FR) 2014-01-22 EP disclosed
EP-2225243-B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof SANOFI SA (FR) 2011-11-16 EP disclosed
EP-2225243-A2 DERIVATIVES OF N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZOÝL,2- A¨PYRIDINE-2-CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF Sanofi-Aventis (FR) 2010-09-08 EP disclosed
WO-2009106751-A2 DERIVATIVES OF N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[L,2- A]PYRIDINE-2-CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2009-09-03 WO disclosed